Add BrightSurf on Google Email

Science News for April 30, 2017


Ivabradine may not benefit certain heart failure patients

A randomized clinical trial found that ivabradine did not improve outcomes in patients with heart failure with preserved ejection fraction. Elevated heart rate is a predictive factor of worse outcomes in these patients, contradicting previous research that suggested benefits for heart failure with reduced ejection fraction.

SourceWiley·JournalEuropean Journal of Heart Failure·DateApr 30, 2017

Non-O blood groups associated with higher risk of heart attack

A meta-analysis of prospective studies reveals that individuals with non-O blood groups (A, B, AB) are at a higher risk of heart attacks and overall cardiovascular mortality. The study found a 9% increased risk of coronary events and cardiovascular mortality in non-O blood group carriers compared to O blood group carriers.

SourceEuropean Society of Cardiology·DateApr 30, 2017
Sky-Watcher EQ6-R Pro Equatorial Mount

Sky-Watcher EQ6-R Pro Equatorial Mount provides precise tracking capacity for deep-sky imaging rigs during long astrophotography sessions.

Method helps determine heart failure patients' risks

A new classification system identifies distinct patient profiles with varying outcomes in acute heart failure hospitalizations. The study provides valuable insights for early triage and treatment decisions.

SourceWiley·JournalEuropean Journal of Heart Failure·DateApr 30, 2017